Boston Scientific (BSX) Technical analysis
Healthcare
Market data as of 2026-09-04 · Autonium metric computed 2026-09-04 · model v1BSX technical analysis — the short answer
BSX is classified Range with a 14-day RSI of 47.7, three-month return of -1.5% and 20-day realised volatility of 37.6%. Autonium's composite Algo Score currently reads unavailable/100.
Price versus moving averages
Last close47.80
20-day49.51-3.5%
50-day46.89+1.9%
100-day50.19-4.8%
200-day66.76-28.4%
Trend classificationRange
Returns
1 week+2.0%
1 month-3.0%
3 months-1.5%
6 months-33.0%
12 months-55.4%
Volatility and drawdown
Realised volatility (20d, annualised)+37.6%
Realised volatility (60d, annualised)+34.3%
1-year volatility percentile67
Current drawdown from peak-55.8%
Deepest 1-year drawdown-60.6%
SPY volatility (20d)+8.1%
Autonium Algo Score
Current score—
7-day change—
30-day change—
90-day change—
1-year range—
Readings above 700
Readings below 300
Signal drivers
MomentumNeutral
Technical trendNeutral
VolatilityNeutral
SentimentNeutral
Sector peers — 3-month return
LLY — Eli Lilly and Co.1.6
UNH — UnitedHealth Group-0.6
JNJ — Johnson & Johnson18.2
ABBV — AbbVie Inc.12.9
MRK — Merck & Co.24.5
Bullish signals
- Price above the 50-day average
Neutral signals
- RSI mid-range at 47.7
- Volatility in the 67th percentile of its own year
- Normal volume regime
Bearish signals
- Price below the 200-day average
- -6.0% three-month excess return vs SPY
Track BSX inside Autonium
Full factor detail, alerts when the score changes, and Toni to ask why.
Continue analysing BSX
Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.